StartupGrind Yerevan is excited to host Amy DuRoss, Co-Founder and CEO at Vineti, a company that creates next-generation technology for healthcare industry and has already raised a total of $47.3M in funding since its start in 2016.
Join us on November 21st for actionable insights in B2B business, practical tips on championing growth for your B2B startup and getting inspired from the amazing success story of Vineti!
Amy has led multiple policy and technology innovations that have helped reshape healthcare in fundamental ways. In addition to leading policy innovations and venture investments, Amy is also driving growth strategy for new business creation portfolio companies and scoping and seeding independent business opportunities. As CEO of Vineti, a cell and gene therapy software and analytics company, she is working on finding ways to overcome the logistical challenges that block widespread patient access to new life-saving treatments.
Before co-founding Vineti, Amy focused on healthcare new business creation for GE Ventures/healthymagination. Prior to GE, Amy was Chief Business Officer at Navigenics, a genomics company sold to Life Technologies in 2012. She was co-founder and Executive Director of Proposition 71, California’s $3B stem cell research initiative passed in 2004, as well as Chief of Staff at the resulting state grant oversight agency. Amy holds an MBA and MA/BA in English from Stanford University. She was named a 2016 Health Innovator Fellow by the Aspen Institute.
Vineti, co-founded by GE and the Mayo Clinic in 2016, develops digital approaches that improve patient safety and streamline the amount of time and money needed to create and deliver therapies. Vineti has raised a total of $47.3M in funding over two rounds. Their latest funding was raised on Apr 16, 2018 in a Series B round. Recently Vineti was selected as a 2019 Technology Pioneer by the World Economic Forum